Neonatal infections are a major cause of newborn mortality in low-resource settings. In view of the World Health Organization’s new 2015 guidelines for outpatient treatment of neonatal sepsis when referral is not feasible, PATH reviewed a range of drug formulation, packaging, and delivery technologies that might be applied to gentamicin delivery for infants at primary care to improve safety, ease of delivery, and potentially expand access.
Corporate author(s): PATH
Publication date: October 2015
1,607 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
- Health technologies > Newborn health
- Health technologies > Vaccine delivery
- Maternal and child health > Safe birth and newborn care
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA